Photo of { Erin Schuler, PhD}

Erin Schuler, PhD


  • Director, Chemistry, Special Chemistry, and Point of Care, Division of Pathology and Laboratory Medicine
  • Assistant Professor, UC Department of Pathology and Laboratory Medicine

About

BS: Dual Major: Chemistry and Biology, Youngstown State University, Youngstown, OH, 2008,

Doctor Of Philosophy: Chemistry, Emory University, Laney Graduate School of Arts and Sciences, Atlanta, GA, 2015,

Fellowship: Chemistry, Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, 2020,

Publications

Precision Dosing of Meropenem in a Neonate on CARPEDIEM Dialysis: A Grand Round. Morales Junior, R; Diseroad, E; Hutson, T; Schuler, EE; Hambrick, HR; Goldstein, SL; Tang Girdwood, S. Therapeutic Drug Monitoring. 2025; 47(6):701-704.

Building a Beta-Lactam Model-Informed Precision Dosing Service in a Quaternary Care Children's Hospital. Tang Girdwood, S; Morales Junior, R; Schuler, E; Tang, P; Diseroad, E; Misch, C; Engle, B; Mccall, S; Murphy, ME; Taylor, ZL; Mizuno, T; Vinks, AA; Kaplan, J. Clinical and Translational Science. 2025; 18(12):e70438.

Population Pharmacokinetics of Cefepime in Critically Ill Children and Young Adults: Model Development and External Validation for Monte Carlo Simulations and Model-Informed Precision Dosing. Morales Junior, R; Hambrick, HR; Mizuno, T; Pavia, KE; Paice, KM; Tang, P; Schuler, E; Krallman, KA; Johnson, L; Collins, M; Gibson, A; Curry, C; Kaplan, J; Goldstein, S; Tang Girdwood, S. Clinical Pharmacokinetics. 2025; 64(4):553-564.

Cystatin C Outperforms Creatinine in Predicting Cefepime Clearance in Pediatric Stem Cell Transplant Recipients. Hambrick, HR; Fei, L; Pavia, K; Kaplan, J; Mizuno, T; Tang, P; Schuler, E; Benoit, S; Girdwood, ST. Transplantation and Cellular Therapy. 2024; 30(6):614.e1-614.e11.

Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells. Hill, KS; Schuler, EE; Ellingson, SR; Kolesar, JM. Scientific Reports. 2023; 13(1):22383.

In Reply to Toward a Clearer Understanding of Accuracy and Proper Application of the IBP4/SHBG Ratio for Predicting Preterm Delivery. Nerenz, RD; Woodworth, A; Farnsworth, C; Schuler, EE. Journal of Applied Laboratory Medicine. 2022; 7(4):1006-1008.

FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply. Almeter, PJ; Isaacs, JT; Hunter, AN; Henderson, BS; Platt, T; Mitchell, BJ; Do, D; Brainard, AB; Brown, JE; Stone, RM; Schuler, EE; Naseman, RW; Johnson, GL; Lodder, RA. Journal of Pharmaceutical Innovation. 2022; 17(2):269-282.

AACC Guidance Document on Laboratory Testing for the Assessment of Preterm Delivery. Farnsworth, C; Schuler, EE; Woodworth, A; Straseski, J; Pschirrer, ER; Nerenz, RD. Journal of Applied Laboratory Medicine. 2021; 6(4):1032-1044.

KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer. Hill, KS; Mcdowell, A; Mccorkle, JR; Schuler, E; Ellingson, SR; Plattner, R; Kolesar, JM. Cancers. 2021; 13(8).

Potential Process Control Issues with Remdesivir. Almeter, PJ; Isaacs, JT; Schuler, EE; Lodder, RA. Contact Context. 2021; 2021.